CO-PRESENTING PARTNERS
LIVE COVERAGE AND VIDEO PARTNERS
PARTNERS
CO-PRESENTING PARTNERS
LIVE COVERAGE AND VIDEO PARTNERS
PARTNERS
Dec 23, 2022 08:30 AM ISTIndian markets logged a third straight day of losses amid renewed Covid fears and RBI minutes that indicated that Governor Shaktikanta Das is not in favour of a pause in rate hikes just yet. Will the selloff continue as we step into the new year? Hemang Jani of Motilal Oswal Financial Services shares his outlook on the market going forward. Also catch NeoTrader’s Raja Venkatraman share his thoughts on stocks like RIL, Thyrocare and RailTel.
Dec 22, 2022 08:53 AM IST Diagnostics stocks saw a smart surge amid renewed fears of Covid outbreaks globally. Shares of Dr Lal PathLabs, Metropolis Healthcare, Vijaya Diagnostic Centre and Thyrocare rallied up to 6% in yesterday as investors see brighter prospects for diagnostics and healthcare businesses amid Covid scare. Catch Santosh Nair's thoughts on whether this rally will sustain and also catch his views on Sula Vineyards which makes its debut on the stock exchanges today and Lupin.
Oct 04, 2022 04:26 PM IST We expect an earnings CAGR in mid-teens in the medium term for VDC on the back of an expansion-led volume growth in the hinterland
Aug 30, 2022 08:08 AM IST European markets were lower on Monday after US Fed Chair Jerome Powell signalled higher interest rates would likely persist in a bid to tame soaring inflation. All sectors and major bourses slipped into negative territory. Tech stocks led the losses, down over 2%. Stocks in the spotlight today – Thyrocare, Orient Cement and BLS International. On the show today we try to decode whether the current market mood is a minor hiccup in the bull run or a deeper correction awaits?
Aug 28, 2022 06:12 PM IST Realising that the idea may take many by surprise, Thyrocare founder Dr Arokiaswamy Velumani revealed that goat farming was his first failure in life and he was only 10.
Jun 01, 2022 10:36 AM IST Thyrocare says the new tagline “Tests you can trust” reflects the transformation of the company over the last 25 years
Jan 05, 2022 03:45 PM IST One question that Thyrocare founder Dr A Velumani strikingly remembers compared him to Elizabeth Holmes, the fallen US biotech star, who was convicted on of defrauding investors in her blood-testing start-up Theranos.
Oct 28, 2021 09:20 AM IST Inorganic growth in this sector has been the norm across the globe, and most countries in the developed world have 5-6 large players dominating the space
Oct 18, 2021 10:40 AM IST Nearly 20 senior employees bought shares worth $5 million as part of the secondary sale while early investors sold their stakes in the firm and IIFL’s tech fund has picked up some stake, the report said.
Sep 15, 2021 09:34 AM IST Going forward, technology will be the differentiator, and Vijay Diagnostic's differentiated hub- and-spoke model calls for attention
Jul 31, 2021 07:19 PM IST Sourav Mallik, who has over 25 years of experience in investment banking and has advised on marquee transactions like Tech Mahindra’s acquisition of Satyam, believes that the Zomato market debut has confirmed that investors have the maturity to understand and appreciate new age companies. His top sectoral picks for deal activity include the digital ecosystem, healthcare, consumer, specialty chemicals and financial services
Jun 28, 2021 05:52 PM IST Dr A Velumani and his family will sell their 66.1 percent stake in Thyrocare to PharmEasy for Rs 4,546 crore. It’s a bumper value-unlocking for the family in the best year possible for the diagnostics business during the pandemic. The need for a change and de-risking are some of the key reasons for the sale, said Dr Velumani.
Jun 28, 2021 12:25 PM IST Siddharth Shah, CEO, API Holdings said that once the acquisition of Thyrocare is complete, Pharmeasy will aim to have its IPO within 6 to 18 months.
Jun 25, 2021 06:48 PM IST Docon Technologies Pvt Ltd, a 100 percent subsidiary of PharmEasy's parent firm API, will be the acquirer and shall make an open offer for an additional 26 percent stake.
Jun 17, 2021 09:44 PM IST Online medical store PharmEasy is in advanced talks to acquire diagnostics services chain Thyrocare in a deal worth about Rs 7,000 crore, people with direct knowledge of the development told Moneycontrol. Nisha Poddar shares the details. Watch:
Jun 17, 2021 01:01 PM IST The deal is likely to be announced soon given the IPO timelines of PharmEasy’s parent, API Holdings, people with direct knowledge of the development said.
Apr 22, 2021 11:15 AM IST Larger players from the diagnostic sector are positioned to gain more than the smaller ones and fragmented market share is an opportunity for them to expand their share.
Dec 11, 2020 08:32 AM IST Vaccine rollout will throw up opportunities not just for the domestic pharmaceutical and healthcare industry but also the logistics value chain, right from vaccine production, delivery, storage and then the actual immunisation
Oct 28, 2020 12:51 PM IST In some states, Thyrocare has been told not to pick up samples, verbally, said A Velumani, CMD & CEO of Thyrocare Technologies
Oct 14, 2020 10:22 AM IST Diagnostic firms such as Dr Lal PathLabs, Thyrocare Technologies and Metropolis Healthcare rebound as COVID-19 related tests drive business growth. While non COVID-19 business is showing signs of normalisation, sustainability of recovery is key
Aug 20, 2020 04:41 PM IST Thyrocare’s findings are in line with government surveys done in Indian cities such as Mumbai, which showed that 57 percent of the population in its crowded slum areas had been exposed to the coronavirus.
Apr 07, 2020 08:47 PM IST The company has announced that it will conduct coronavirus testing on a zero-profit basis for the next one year.
Apr 01, 2020 02:28 PM IST Private lab chain Thyrocare has tied up with digital healthcare platform Practo to enable booking of COVID-19 test kits online.
Mar 31, 2020 07:39 PM IST Patients with a valid doctor’s prescription and a requisition form filled and signed by the doctor will be allowed to opt for the test.
Mar 28, 2020 07:53 PM IST Any patient with a valid doctor’s prescription and a requisition form filled and signed by the doctor will be allowed to opt for a Covid-19 test.
